BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →

Loading VIVS charts…

Search ticker or company⌘K

VIVS

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

VIVS · VivoSim Labs, INC. fundamentals · vpside

vpside

⌘K

VIVSMarket cap $804781/Last filing 10-Q, Q1 FY27 · 12 Aug 2026/VIVSMarket cap $804781/Last filing 10-Q, Q1 FY27 · 12 Aug 2026/VIVSMarket cap $804781/Last filing 10-Q, Q1 FY27 · 12 Aug 2026/VIVSMarket cap $804781/Last filing 10-Q, Q1 FY27 · 12 Aug 2026/

Filings synced 13:22 · Prices: prior close 30 Oct

VIVS

VivoSim Labs, INC.

Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Mar

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

$18000−51.4% year on year

$2M$1M$500000$0

vpside.com

Q2 ’22Q3 ’23Q4 ’24Q4 ’25Q1 ’27

Company filings · 10-Q filed 12 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

100.0%+3.5 pp year on year

100%98%96%

vpside.com

Q1 ’22Q2 ’23Q3 ’24Q3 ’25Q4 ’26

Company filings · 10-K filed 14 Jul 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$2M−81.6% year on year

$40M$20M$0

vpside.com

Q2 ’22Q3 ’23Q4 ’24Q4 ’25Q1 ’27

Company filings · 10-Q filed 12 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$10M

$10M$0−$10M−$20M

vpside.com

Q2 ’22Q3 ’23Q4 ’24Q4 ’25Q1 ’27

Company filings · 10-Q filed 12 Aug 2026 · TTM = last four quartersvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters